Blog

Actos Lawsuits Consolidated in Western District of Louisiana

by Stacey E. Burke on 01/06/2012

On December 28, 2011, the U.S. District Court for the Western District of Louisiana consented to the assignment of all federal Actos cases to the Honorable Rebecca F. Doherty. To date, more than 100 Actos bladder cancer lawsuits have been or will be transferred to the Western District of Louisiana. As the litigation continues, the number of cases within the Actos MDL will only continue to increase.

Plaintiffs are suing Takeda Pharmaceuticals America Inc. (Takeda), the manufacturer of Actos, and other responsible entities for a variety of pharmaceutical product liability claims. The Louisiana Actos consolidation avoids document duplications and inconsistent rulings, while also potentially saving resources expended upon expert testimony.

Actos has been scientifically linked to the development of an increased risk of bladder cancer. The U.S. Food and Drug Administration (FDA) required Takeda to add warnings to their Actos label, indicating that the medication may increase the risk of bladder cancer (bladder tumors) when taken for more than a year. Additionally, the newly updated drug label now recommends that healthcare providers should not prescribe Actos for patients with bladder cancer and should use it with caution in patients with a prior history of bladder cancer.

When Actos launched in America in 1999, the diabetes medication was jointly marketed by Takeda and Eli Lilly & Company; however as of 2006, Takeda solely assumed all marketing and sales responsibilities. For those who take Actos, bladder cancer symptoms may include: blood in urine, painful urination, frequent small amounts of urination, frequent urinary tract infections, and back or pelvic pain.

Mikal C. Watts, his Partner Ryan L. Thompson, and the mass tort lawyers of Watts Guerra Craft have been involved in the Actos litigation since the beginning.  Mr. Watts is leading a team of experienced defective drug lawyers, handling a solid, large group of bladder cancer claims.  Our mass tort department is also investigating cases involving, Accutane, Fosamax, Transvaginal Mesh Devices, Paxil, Zoloft, Depuy ASR Hip Recall, DePuy Pinnacle Hip Recall, and more.

Do not wait to get free legal advice about your Actos bladder cancer or other pharmaceutical product liability claim today.  Contact the lawyers of Watts Guerra Craft now.

Tags: Watts Guerra Craft, Actos, Pharmaceutical Mass Torts

blog comments powered by Disqus